![]() |
Market Research Report
Product code
1042951
In Situ Hybridization Market Size, Share & Trends Analysis Report By Technology (FISH, CISH), By Probe Type (DNA, RNA), By Product, By Application, By End-user (CROs), By Region, And Segment Forecasts, 2021 - 2028 |
In Situ Hybridization Market Size, Share & Trends Analysis Report By Technology (FISH, CISH), By Probe Type (DNA, RNA), By Product, By Application, By End-user (CROs), By Region, And Segment Forecasts, 2021 - 2028 |
Published: December 13, 2021
Grand View Research, Inc.
Content info: 117 Pages
Delivery time: 2-10 business days
|
The global in situ hybridization market size is expected to reach USD 2.6 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.9% from 2021 to 2028. The growing popularity of in-vitro diagnostics over conventional disease diagnostic methods has majorly driven the ISH market over the past years.
The market is gaining momentum in breast cancer with the FISH test. For instance, Roche offers a comprehensive ISH workflow solution with automated assay and digital pathology for breast cancer. Thus, increasing the scope of application is expected to drive the market to a major extend. In addition, technological advancements in instruments have fueled the market growth.
The COVID-19 is found to have a mixed impact on the market space. Social distancing mandates and lockdown policies have negatively affected the market to a considerable extent. However, the pandemic has opened new opportunities for operating entities by allowing them to deploy ISH methods in the R&D of COVID-19 related programs.
The leading institutions and market competitors are now focusing on designing fluorescence in situ hybridization probes to visualize COVID-19 RNA in the infected cells. FISH has proven to offer relevant information on the virus at a cost-effective method.